Janssen Expanding Its Disease Interception Efforts
This article was originally published in The Pink Sheet Daily
Executive Summary
Through a series of research agreements, J&J arm is seeking to create new business models teaming a single internal expert with a host of external researchers in six priority therapeutic areas.